Bank of Montreal’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.5K | Buy |
+30,069
| New | +$72.5K | ﹤0.01% | 2772 |
|
|
2025
Q1 | – | Sell |
-77,679
| Closed | -$423K | – | 3230 |
|
|
2024
Q4 | $423K | Buy |
+77,679
| New | +$423K | ﹤0.01% | 2061 |
|
|
2024
Q3 | – | Sell |
-27,306
| Closed | -$284K | – | 3700 |
|
|
2024
Q2 | $284K | Buy |
27,306
+3,291
| +14% | +$34.2K | ﹤0.01% | 2510 |
|
|
2024
Q1 | $210K | Sell |
24,015
-9,000
| -27% | -$78.7K | ﹤0.01% | 2723 |
|
|
2023
Q4 | $222K | Buy |
+33,015
| New | +$222K | ﹤0.01% | 2659 |
|
|
2023
Q2 | – | Sell |
-50,478
| Closed | -$713K | – | 3710 |
|
|
2023
Q1 | $713K | Buy |
+50,478
| New | +$713K | ﹤0.01% | 2021 |
|
|
2022
Q4 | – | Sell |
-26,336
| Closed | -$674 | – | 3597 |
|
|
2022
Q3 | $674 | Buy |
26,336
+2,881
| +12% | +$74 | ﹤0.01% | 2040 |
|
|
2022
Q2 | $654 | Buy |
23,455
+6,892
| +42% | +$192 | ﹤0.01% | 2173 |
|
|
2022
Q1 | $591K | Buy |
16,563
+1,986
| +14% | +$70.9K | ﹤0.01% | 2277 |
|
|
2021
Q4 | $613K | Sell |
14,577
-656
| -4% | -$27.6K | ﹤0.01% | 2187 |
|
|
2021
Q3 | $738K | Sell |
15,233
-10,727
| -41% | -$520K | ﹤0.01% | 2487 |
|
|
2021
Q2 | $1.12M | Buy |
25,960
+14,985
| +137% | +$646K | ﹤0.01% | 2292 |
|
|
2021
Q1 | $365K | Buy |
+10,975
| New | +$365K | ﹤0.01% | 2482 |
|